Panel discussion

Date:April 22, 2024

Panel title

Driving Clinical Development During Challenging Financial Times

Panel summary

Are financial challenges hindering your clinical development journey? How to secure funding in today’s evolving landscape?
Amidst a dynamic financial environment impacting drug development across the globe, companies need to make the right decisions in order to thrive.
Join our session to learn from the experiences of experts from Venture Capital, Biotechnology, and the Contract Research space, who will deliver actionable insights to help you lead through challenging times.

Speaker information


Dr. Oren Cohen, Chief Medical Officer and President of Clinical Pharmacology, Fortrea


Erik van den Berg, CEO, Memo Therapeutics
Daniela Schmitter, Head of Clinical Operations, Alentis Therapeutics
Marc Lohrmann, Managing Partner, Vesalius Biocapital III
Alison Foster, VP Strategic Delivery and Growth, Fortrea

Company profile

Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry partnering with all sizes of biopharma, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services in 90 countries and 20 TAs.

Further information

Follow us